别名:B37; HRS; NOD; DRPLA; D12S755E应用:IHC
反应种属:Human, Mouse, Rat
规格:50μl/100μl
| Description |
|---|
| Dentatorubral pallidoluysian atrophy (DRPLA) is a rare neurodegenerative disorder characterized by cerebellar ataxia, myoclonic epilepsy, choreoathetosis, and dementia. The disorder is related to the expansion from 7-23 copies to 49-75 copies of a trinucleotide repeat (CAG/CAA) within this gene. The encoded protein includes a serine repeat and a region of alternating acidic and basic amino acids, as well as the variable glutamine repeat. Alternative splicing results in two transcripts variants that encode the same protein. |
| Specification | |
|---|---|
| Aliases | B37; HRS; NOD; DRPLA; D12S755E |
| Swissprot | P54259 |
| Host/Isotype | Rabbit IgG |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse, Rat |
| Immunogen | Synthetic peptide of human ATN1 |
| Formulation | pH7.4 PBS, 0.05% NaN3, 40% Glycerol |
| Application | |
|---|---|
| IHC | 1/40-1/200 |
| ELISA | 1/5000-1/10000 |
![]() |
The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P06044(ATN1 Antibody) at dilution 1/50. (Original magnification: ×200) |
![]() |
The image is immunohistochemistry of paraffin-embedded Human ovarian cancer tissue using P06044(ATN1 Antibody) at dilution 1/50. (Original magnification: ×200) |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
中文


发表回复